Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 4, 2024 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantStock Options (Right to buy) · Derivative | 54,945 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001562180-24-000219 · primarydocument.xml · derivative · entry 3 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,945 Underlying: Common Stock · 54,945 shares Expires 2034-01-02 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantCommon Stock | 34,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000219 · primarydocument.xml · nonDerivative · entry 2 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,759 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
Tax withholdingCommon Stock | 7,893 | $17.95 | $141,679.35 |
DisclosureSEC source: 0001562180-24-000219 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,144 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 18:38 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-23-008519 · primarydocument.xml · derivative · entry 5 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,316 Underlying: Common Stock · 1,500 shares Expires 2024-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 1,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on September 24, 2015, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 18:38 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 43,500 | $0.00 Strike: $3.76 | $0.00 |
DisclosureSEC source: 0001562180-23-008519 · primarydocument.xml · derivative · entry 4 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,354 Underlying: Common Stock · 43,500 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 43,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 9, 2016, and the balance vested in equal monthly installments over the 36 months thereafter. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 18:38 UTC |
Mills Kenneth T.Director · President and CEO
|
SaleCommon Stock | 45,000 | $19.69 | $885,825.00 |
DisclosureSEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,289 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.48 to $20.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 18:38 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 1,500 | $0.85 | $1,275.00 |
DisclosureSEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 18:38 UTC |
Mills Kenneth T.Director · President and CEO
|
Exercise / conversionCommon Stock | 43,500 | $3.76 | $163,560.00 |
DisclosureSEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 398,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 30, 2023 Filed Jan 4, 2024 16:22 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 1,123 | $16.99 | $19,081.45 |
DisclosureSEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,801 F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2023 through June 30, 2023. This transaction is exempt under Rule 16b-3(c). F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2023. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:11 UTC |
Bennett JeanDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004889 · primarydocument.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:11 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004889 · primarydocument.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
MIGAUSKY GEORGE VDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004892 · primarydocument.xml · derivative · entry 2 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
MIGAUSKY GEORGE VDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004892 · primarydocument.xml · nonDerivative · entry 1 MIGAUSKY GEORGE V · CIK 0001134365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:11 UTC |
Zachary JenniferDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004888 · primarydocument.xml · derivative · entry 2 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:11 UTC |
Zachary JenniferDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004888 · primarydocument.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,506 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
Glucksmann AlexandraDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004891 · primarydocument.xml · derivative · entry 2 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
Glucksmann AlexandraDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004891 · primarydocument.xml · nonDerivative · entry 1 Glucksmann Alexandra · CIK 0001658390 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:14 UTC |
Fox Allan M.Director
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004896 · primarydocument.xml · derivative · entry 6 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:14 UTC |
Fox Allan M.Director
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004896 · primarydocument.xml · nonDerivative · entry 1 Fox Allan M. · CIK 0001652936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
STUMP DAVID CDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004893 · primarydocument.xml · derivative · entry 2 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
STUMP DAVID CDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004893 · primarydocument.xml · nonDerivative · entry 1 STUMP DAVID C · CIK 0001191235 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
KARABELAS ARGERIS NDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004890 · primarydocument.xml · derivative · entry 2 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:12 UTC |
KARABELAS ARGERIS NDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004890 · primarydocument.xml · nonDerivative · entry 1 KARABELAS ARGERIS N · CIK 0001191229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:13 UTC |
Tasse DanielDirector
|
GrantStock Options (Right to Buy) · Derivative | 17,892 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001562180-23-004894 · primarydocument.xml · derivative · entry 2 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 Underlying: Common Stock · 17,892 shares Expires 2033-06-02 F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 21:13 UTC |
Tasse DanielDirector
|
GrantCommon Stock | 3,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004894 · primarydocument.xml · nonDerivative · entry 1 Tasse Daniel · CIK 0001502785 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:12 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001562180-23-004722 · primarydocument.xml · derivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2024-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter. F2 · derivative.exercise_date: Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 16:12 UTC |
Vasista VittalChief Financial Officer
|
Exercise / conversionCommon Stock | 35,000 | $0.85 | $29,750.00 |
DisclosureSEC source: 0001562180-23-004722 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantStock Options (Right to buy) · Derivative | 44,155 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000222 · primarydocument.xml · derivative · entry 4 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,155 Underlying: Common Stock · 44,155 shares Expires 2033-01-03 F5 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
PAKOLA STEVEChief Medical Officer
|
GrantCommon Stock | 90,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 3 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,763 F4 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
PAKOLA STEVEChief Medical Officer
|
SaleCommon Stock | 3,138 | $22.17 | $69,559.42 |
DisclosureSEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 2 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,175 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.0000 to $22.3800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
PAKOLA STEVEChief Medical Officer
|
Tax withholdingCommon Stock | 1,837 | $22.68 | $41,663.16 |
DisclosureSEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 1 PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,313 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Danos OlivierChief Scientific Officer
|
GrantStock Options (Right to buy) · Derivative | 52,986 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000220 · primarydocument.xml · derivative · entry 3 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,986 Underlying: Common Stock · 52,986 shares Expires 2033-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Danos OlivierChief Scientific Officer
|
GrantCommon Stock | 65,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000220 · primarydocument.xml · nonDerivative · entry 2 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,950 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Danos OlivierChief Scientific Officer
|
Tax withholdingCommon Stock | 2,058 | $22.68 | $46,675.44 |
DisclosureSEC source: 0001562180-23-000220 · primarydocument.xml · nonDerivative · entry 1 Danos Olivier · CIK 0001701180 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,020 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantStock Options (Right to buy) · Derivative | 264,932 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000221 · primarydocument.xml · derivative · entry 3 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,932 Underlying: Common Stock · 264,932 shares Expires 2033-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
GrantCommon Stock | 54,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000221 · primarydocument.xml · nonDerivative · entry 2 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,289 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Mills Kenneth T.Director · President and CEO
|
Tax withholdingCommon Stock | 9,308 | $22.68 | $211,105.44 |
DisclosureSEC source: 0001562180-23-000221 · primarydocument.xml · nonDerivative · entry 1 Mills Kenneth T. · CIK 0001652824 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,536 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Vasista VittalChief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 66,233 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000224 · primarydocument.xml · derivative · entry 3 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,233 Underlying: Common Stock · 66,233 shares Expires 2033-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Vasista VittalChief Financial Officer
|
GrantCommon Stock | 46,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000224 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,001 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 16:06 UTC |
Vasista VittalChief Financial Officer
|
Tax withholdingCommon Stock | 1,333 | $22.68 | $30,232.44 |
DisclosureSEC source: 0001562180-23-000224 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,827 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantStock Options (Right to buy) · Derivative | 52,986 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000223 · primarydocument.xml · derivative · entry 3 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,986 Underlying: Common Stock · 52,986 shares Expires 2033-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
GrantCommon Stock | 67,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000223 · primarydocument.xml · nonDerivative · entry 2 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,985 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Simpson CurranChief Oper. & Tech. Officer
|
Tax withholdingCommon Stock | 2,076 | $22.68 | $47,083.68 |
DisclosureSEC source: 0001562180-23-000223 · primarydocument.xml · nonDerivative · entry 1 Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,040 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantStock Options (Right to buy) · Derivative | 56,519 | $0.00 Strike: $22.25 | $0.00 |
DisclosureSEC source: 0001562180-23-000219 · primarydocument.xml · derivative · entry 3 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,519 Underlying: Common Stock · 56,519 shares Expires 2033-01-03 F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
GrantCommon Stock | 67,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000219 · primarydocument.xml · nonDerivative · entry 2 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,037 F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:06 UTC |
Christmas Patrick J.Chief Legal Officer
|
Tax withholdingCommon Stock | 1,843 | $22.68 | $41,799.24 |
DisclosureSEC source: 0001562180-23-000219 · primarydocument.xml · nonDerivative · entry 1 Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,097 F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 18:01 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,400 | $30.24 | $72,572.64 |
DisclosureSEC source: 0001562180-22-006398 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,160 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.04 to $30.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 16:04 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 17,280 | $35.19 | $608,034.82 |
DisclosureSEC source: 0001562180-22-005938 · primarydocument.xml · nonDerivative · entry 2 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,560 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 16:04 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 400 | $35.00 | $14,000.00 |
DisclosureSEC source: 0001562180-22-005938 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,840 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:26 UTC |
Vasista VittalChief Financial Officer
|
SaleCommon Stock | 2,400 | $31.26 | $75,012.00 |
DisclosureSEC source: 0001562180-22-005876 · primarydocument.xml · nonDerivative · entry 1 Vasista Vittal · CIK 0001652827 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,240 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.85 to $31.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.